These results demonstrated that salusin-β could increase the expressions of inflammatory factors, at least in part, through increasing the activation of the I-κBα/NF-κB pathway, which might be one of the mechanisms for salusin-β to accelerate the progression of atherosclerosis. Here, NFKBIA is linked to atherosclerosis.